| 摘要: |
| [目的] 综合评价醒脑静注射液上市后用药的安全性,对中药注射剂上市后安全性再评价进行综合研究。[方法] 临床药师对本院针灸科使用醒脑静注射液的住院患者,从用药开始至用药结束15 d进行跟踪,填写评价筛选表,进行统计分析。[结果] 共观察1 252例患者,未发生不良反应。[结论] 在该研究中,醒脑静注射液未发生不良反应,临床应用相对安全。 |
| 关键词: 醒脑静注射液 上市后安全性再评价 不良反应 |
| DOI：10.11656/j.issn.1672-1519.2015.05.15 |
| 分类号: |
| 基金项目:天津市卫生局中医、中西医结合科研课题(07010). |
|
| Study on the post-marketing reassessment of Xingnaojing injection |
|
CHEN Xiao-xu, DONG Gai-ying
|
|
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
|
| Abstract: |
| [Objective] To evaluate the safety of Xingnaojing injection as post-marketing drug, comprehensive study on safety evaluation of post-market traditional Chinese medicine injection. [Methods] Clinical pharmacists collect patients used Xingnaojing injection in acupuncture and moxibustion department of our hospital from beginning to end, totally 15 days of tracking, fill out the evaluation table, analyse the statistics. [Results] There were 1 252 patients in total, with no adverse reaction. [Conclusion] In this study, the effect of Xingnaojing injection has no adverse reaction, and the safety of clinical application is proved. |
| Key words: Xingnaojing injection safety evaluation of postmarketing adverse reaction |
